Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R De Groot

Showing results (411-420 of 467) with videos related to

Pageof 47
Sort By:
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Frontiers in Immunology|May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell TransplantationsKirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 5, 2019
Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidenceEmanuele Bertaglia, Benjamin Blank, Carina Blomström-Lundqvist, et al.
Clinical and Translational Medicine|November 29, 2021
Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillationNicoline W E van den Berg, Makiri Kawasaki, Benedetta Fabrizi, et al.
Journal of the American Heart Association|December 25, 2017
Pacemaker-Mediated Programmable Hypertension Control TherapyPetr Neuzil, Béla Merkely, Andrejs Erglis, et al.
International Journal of Molecular Sciences|February 13, 2026
Atrial Fibrillation and Primary Cilia-Associated Genes: The Role of CEP68Zhenyu Dong, Rushd F M Al-Shama, Nicoline W E van den Berg, et al.
Scientific Reports|February 4, 2021
Neutrophil degranulation interconnects over-represented biological processes in atrial fibrillationMakiri Kawasaki, Eva R Meulendijks, Nicoline W E van den Berg, et al.
Pageof 47

Showing results (411-420 of 467) with videos related to

Sort By:
Pageof 47
Thrombosis and Haemostasis|February 23, 2010
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorderAnna Savoia, Daniela De Rocco, Emanuele Panza, et al.
Frontiers in Immunology|May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell TransplantationsKirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2020
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe studyJoris R de Groot, Thomas W Weiss, Peter Kelly, et al.
Lancet (London, England)|September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trialAndreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 5, 2019
Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidenceEmanuele Bertaglia, Benjamin Blank, Carina Blomström-Lundqvist, et al.
Clinical and Translational Medicine|November 29, 2021
Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillationNicoline W E van den Berg, Makiri Kawasaki, Benedetta Fabrizi, et al.
Journal of the American Heart Association|December 25, 2017
Pacemaker-Mediated Programmable Hypertension Control TherapyPetr Neuzil, Béla Merkely, Andrejs Erglis, et al.
International Journal of Molecular Sciences|February 13, 2026
Atrial Fibrillation and Primary Cilia-Associated Genes: The Role of CEP68Zhenyu Dong, Rushd F M Al-Shama, Nicoline W E van den Berg, et al.
Scientific Reports|February 4, 2021
Neutrophil degranulation interconnects over-represented biological processes in atrial fibrillationMakiri Kawasaki, Eva R Meulendijks, Nicoline W E van den Berg, et al.
Pageof 47